The use of lipid-lowering drugs in children

Journal of Clinical Lipidology

Volumn 4, Issue 6, 2010, Pages 449-461

  Brown, W Virgil ^a   Wilson, Don P ^b   Freemark, Michael ^c   Kwiterovich, Peter O ^d,e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c DUKE UNIVERSITY   (United States)

^d Lipid Research and Atherosclerosis Division   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID SEQUESTRANT; EZETIMIBE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LINOLEIC ACID; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; NICOTINIC ACID; OMEGA 3 FATTY ACID; PRAVASTATIN; THIOCYANATE; TRIACYLGLYCEROL;

ACUTE PANCREATITIS; AORTA FLOW; AORTA STENOSIS; APHERESIS; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; BODY MASS; CARBOHYDRATE INTAKE; CARDIOVASCULAR RISK; CHILDHOOD DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; CORONARY ARTERY DISEASE; DISEASE MARKER; DISEASE SEVERITY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DYSLIPIDEMIA; DYSPEPSIA; EARLY DIAGNOSIS; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; GENDER; GLYCEMIC CONTROL; HEALTH CARE COST; HOMOZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPID ANALYSIS; LIPID METABOLISM; MEDICAL PRACTICE; METABOLIC SYNDROME X; MONOTHERAPY; MYALGIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK REDUCTION; SECONDARY PREVENTION; SITOSTEROLEMIA; SMOKING; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT;

CARDIOVASCULAR DISEASES; CHILD; CHOLESTEROL, LDL; HUMANS; HYPOLIPIDEMIC AGENTS; RISK FACTORS; TRIGLYCERIDES;

EID: 78649653592     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.10.003     Document Type: Conference Paper

References (18)

1. G.S. Berenson, S.R. Srinivasan, W. Bao, W.P. Newman 3rd, R.E. Tracy, and W.A. Wattigney Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study N Engl J Med 338 23 1998 1650 1656
2. W.V. Brown, C.M. Ballantyne, P.H. Jones, and s. Marcovina Management of Lp(a): Review Article J Clin Lipidology 4 4 2010 240 247
3. W. Chen, S.R. Srinivasan, J. Xu, and G.S. Berenson Effect of parental coronary artery disease on adverse effects of the metabolic syndrome and aging on carotid artery intima-media thickness (from the Bogalusa Heart Study) Am J Cardiol 102 2 2008 180 183
4. S. Clauss, K.M. Wai, R.E. Kavey, and K. Kuehl Ezetimibe treatment of pediatric patients with hypercholesterolemia J Pediatr 154 6 2009 869 872
5. S. Daniels, F. Greer Committee on Nutrition Clinical Report: Lipid Screening and Cardiovascular Health in Childhood 2008 American Academy of Pediatrics Elk Grove Village, IL
6. J.C. Feoli-Fonseca, E. Lévy, M. Godard, and M. Lambert Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study J Pediatr 133 3 1998 417 423
7. D.S. Freedman, Y.C. Wang, W.H. Dietz, J.H. Xu, S.R. Srinivasan, and G.S. Berenson Changes and variability in high levels of low-density lipoprotein cholesterol among children Pediatrics 126 2 2010 266 273
8. E.M. Haney, L.H. Huffman, C. Bougatsos, M. Freeman, R.D. Steiner, and H.D. Nelson Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force Pediatrics 120 1 2007 e189 e214
9. L.C. Hudgins, B. Kleinman, A. Scheuer, S. White, and B.R. Gordon Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia Am J Cardiol 102 9 2008 1199 1204
10. P.O. Kwitoverich Recognition and management of dyslipidemia in children and adolescents J Clin Endocrinol Metab 93 11 2008 4200 4209
11. S. Li, W. Chen, S.R. Srinivasan, M.G. Bond, R. Tang, E.M. Urbina, and G.S. Berenson Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study JAMA 290 17 2003 2271 2276
12. C.G. Magnussen, A. Venn, and R. Thomson The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study J Am Coll Cardiol 53 10 2009 860 869
13. C.G. Magnussen, A. Venn, and R. Thomson The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Wiegman A, Rodenburg J, de Jongh S, et al, eds. Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children Circulation 107 11 2003 1473 1478
14. B. McCrindle Pathogenesis and management of dyslipidemia in obese children M. Freemark, Pediatric Obesity: Etiology, Pathogenesis and Treatment 2010 Humana Press, Springer New York, NY 175 200
15. C.A. McMahan, H.C. McGill, and S.S. Gidding Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. PDAY risk score predicts advanced coronary artery atherosclerosis in middle-aged persons as well as youth Atherosclerosis 190 2007 370 377
16. T.O. Obisesan, M.H. Aliyu, A.S. Adediran, V. Bond, C.J. Maxwell, and C.N. Rotimi Correlates of serum lipoprotein (A) in children and adolescents in the United States. The third National Health Nutrition and Examination Survey (NHANES-III) Lipids Health Dis 3 2004 29
17. A.R. Rahalkar, and R.A. Hegele Monogenic pediatric dyslipidemias: classification, genetics and clinical spectrum Mol Genet Metab 93 2008 282 294
18. A. Wiegman, B.A. Hutten, and E. de Groot Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial JAMA 292 2004 331 337